tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Income Statement

Compare
445 Followers

Spyre Therapeutics Income Statement

Last quarter (Q4 2024), Spyre Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Spyre Therapeutics's net income was $-56.30M. See Spyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 886.00K$ 2.33M$ 18.74M$ 0.00
Gross Profit
$ 0.00$ -78.00K$ 365.00K$ 16.74M$ -1.62M
Operating Expenses
$ 208.57M$ 243.19M$ 87.11M$ 84.39M$ 81.48M
Depreciation and Amortization
$ 0.00$ 964.00K$ 1.96M$ 2.00M$ 1.62M
EBITDA
$ -208.57M$ -127.82M$ -83.21M$ -63.66M$ -79.27M
Operating Income
$ -208.57M$ -242.30M$ -84.78M$ -65.65M$ -81.48M
Other Income/Expenses
$ 599.00K$ -96.51M$ 830.00K$ -11.00K$ 588.00K
Pretax Income
$ -207.97M$ -338.82M$ -83.95M$ -65.66M$ -80.89M
Net Income
$ -208.02M$ -338.79M$ -83.81M$ -65.80M$ -80.89M
Per Share Metrics
Basic EPS
$ -0.56$ -46.15$ -24.86$ -25.02$ -37.89
Diluted EPS
$ -0.56$ -46.15$ -24.86$ -25.02$ -37.89
Weighted Average Shares Outstanding
374.39M 7.34M 3.37M 2.63M 2.13M
Weighted Average Shares Outstanding (Diluted)
374.39M 7.34M 3.37M 2.63M 2.13M
Currency in USD

Spyre Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis